Abstract
In The Lancet, Kate Causey and colleagues1 report their estimates of the disruptions to routine childhood immunisation coverage for the third-dose diphtheria-tetanus-pertussis (DTP3) vaccine and first-dose measles-containing vaccine (MCV1) at the global, regional, and national levels due to the COVID-19 pandemic. These modelled estimates are of importance to national immunisation programmes for planning and implementing catch-up vaccination services to close the immunity gaps and prevent vaccine-preventable disease outbreaks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
